GLPwatch
GLP-1 Receptor Expression in CHI
NCT03768518 · Unknown status
Last updated 2026-05-28This study is looking at how a certain protein (GLP-1 receptor) is distributed in the pancreas of children with a condition called congenital hyperinsulinism.
Status Unknown status The sponsor has not confirmed the status recently.
Type Observational
Participants 40 people Planned (estimated).
Who can join Up to age 16 · all sexes
Timeline Started 2018-02 · est. completion 2019-02
Where 1 site · Netherlands
What this study is testing ClinicalTrials.gov NCT03768518 ↗
Description as written by the study sponsor.
The primary objective is the in vivo and ex vivo investigation of the expression and distribution of the GLP-1R in the pancreas of CHI patients.
Treatments tested
- 68Ga-exendin-4 PET/CT Diagnostic test
68Ga-exendin-4 PET/CT
| Main thing measured | Expression and distribution of GLP-1R in pancreas of children with CHI |
|---|---|
| Sponsor | Radboud University Medical Center |
| Conditions studied | Congenital Hyperinsulinism |
| GLP-1 drugs | — |
Full protocol, eligibility, and contacts on ClinicalTrials.gov NCT03768518 ↗